ѻý

Cancer Drugs That Didn't Work; Another HIV Cure; Kiss of Success With Mistletoe

<ѻý class="mpt-content-deck">— News, features, and commentary about cancer-related issues
MedpageToday
Onco Break over a computer rendering of a cancer cell.

A study of more than 4,000 patients treated with anticancer drugs that received showed that a fourth of the patients received a drug whose approval was subsequently withdrawn. (JAMA Oncology)

Older adults with terminal cancer received more often when they were in nursing homes versus community settings. (JAMA Network Open)

Researchers from Germany announced that a third patient has been cured of HIV following . (German Center for Infection Research, Nature Medicine)

The formerly controversial drug thalidomide showed promise for reducing . (Science Translational Medicine)

FDA Commissioner Robert Califf, MD, outlined a series of "next steps" to strengthen the agency's .

Discovery of previously unreported effects of human papillomavirus (HPV) on may lead to a better understanding of how the virus causes cancer and possibly to more effective treatment strategies. (University of Texas MD Anderson Cancer Center, Cancer Discovery)

A preliminary study of a treatment derived from yielded evidence of improved quality of life and possibly anticancer activity in patients with advanced solid tumors. (Johns Hopkins Medicine, Cancer Research Communications)

Researchers reported new insights into how colorectal cancer cells develop . (Hospital del Mar Medical Research Institute, Nature Communications)

Using a new form of endoscopy, gastrointestinal cancer specialists achieved greater than 90% accuracy for detection and diagnosis of without the need for biopsy. (Second Affiliated Hospital of Baotou Medical College, Gastroenterology and Endoscopy)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined ѻý in 2007.